Sarcoma, Ewing
-
Subject Areas on Research
- 5-Fluorouracil in childhood solid tumors.
- A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
- A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
- Aberrant expression of tumor suppressor proteins in the Ewing family of tumors.
- Allografts about the Knee in Young Patients with High-Grade Sarcoma.
- An evolutionary framework for treating pediatric sarcomas.
- An exploratory study of environmental and medical factors potentially related to childhood cancer.
- Biphenotypic sarcoma with characteristics of both a Ewing sarcoma and a desmoplastic small round cell tumor.
- Central nervous system extraosseous Ewing sarcoma: radiologic manifestations of this newly defined pathologic entity.
- EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.
- Epidemiologic and survival trends in adult primary bone tumors of the spine.
- Ewing's sarcoma of the hand.
- Ewing's sarcoma.
- Ewing's tumor and papillary adenocarcinoma of the thyroid in a 14-year-old girl.
- Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
- Imaging of primary Ewing sarcoma with 13N-L-glutamate.
- In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues.
- Incidence of anemia in children with solid tumors or Hodgkin disease.
- Inhibition of notch signaling induces neural differentiation in Ewing sarcoma.
- Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.
- Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
- Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing Program.
- Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program.
- Intracranial Ewing sarcoma.
- Local complications after limb-salvage surgery for pediatric bone tumours: a pictorial essay.
- Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study.
- Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
- Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents.
- Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
- NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
- Pediatric radiation oncology.
- Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
- Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
- Primary intracranial Ewing's sarcoma with unusual features.
- Primary intradural extraosseous Ewing sarcoma of the spine: case report and literature review.
- Radiosurgical treatment for Ewing's sarcoma of the lumbar spine: case report.
- Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.
- Reply to Second malignancies in Ewing sarcoma survivors.
- Stress fractures of the proximal tibia in runners.
- Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program.
- The problem of benign pulmonary nodules in children receiving cytotoxic chemotherapy.
- [Femur reconstruction using combined autologous fibula transfer and humeral allograft].
-
Keywords of People
- Oristian, Kristi, Research Technician II, Pharmacology & Cancer Biology